Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas

ONIRIS254 enrolled

Overview

The main objective is to evaluate middle term compliance (≥ 2 years) of the Mandibular Advancement Devices Tali® in patients with Syndrome of Obstructive Sleep Apnea and Hypopneas.

Study Type

OBSERVATIONAL

Enrollment

254

Conditions

Syndrome of Obstructive Sleep Apnea and Hypopneas

Interventions

Mandibular Advancement DevicesDEVICE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients \> 18 years treated with Mandibular Advancement Device Tali® from at least 2 years and at the latest 5 years. * Patients who agree to participate to the study.

Locations (1)

Liberal cabinet

Paris, France

Outcomes

Primary Outcomes

compliance (no stop of the Mandibular Advancement Device)

Time frame: 2 years or more after the beginning of device

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.